Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx industry and campaign finance reform

Executive Summary

The pharmaceutical industry-funded Citizens for Better Medicare advocacy group is cited as an example of disguised electioneering during Sept. 8 oral arguments before the Supreme Court over the McCain/Feingold campaign finance reform law. Wilmer, Cutler & Pickering Partner Seth Waxman, representing Sen. John McCain (R-Ariz.) in supporting the law, noted that CBM described itself as "a group of concerned seniors and companies and associations concerned about Medicare." It was "in fact funded almost exclusively by PhRMA and the companies that make up PhRMA," he continued. The association ran 23,867 "issue ads" about Medicare from Jan. 1 until Sept. 4 "and not a single one mentioned a candidate." In the last 60 days before the elections, "they ran 10,876 ads, all mentioning candidates." Then, "on election day, they stopped cold"...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel